Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.
Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, A'Hern R, Bliss J, Bogaerts J, Bonnefoi H, Brain E, Cardoso MJ, Chibaudel B, Coleman R, Cufer T, Dal Lago L, Dalenc F, De Azambuja E, Debled M, Delaloge S, Filleron T, Gligorov J, Gutowski M, Jacot W, Kirkove C, MacGrogan G, Michiels S, Negreiros I, Offersen BV, Penault Llorca F, Pruneri G, Roche H, Russell NS, Schmitt F, Servent V, Thürlimann B, Untch M, van der Hage JA, van Tienhoven G, Wildiers H, Yarnold J, Bonnetain F, Mathoulin-Pélissier S, Bellera C, Dabakuyo-Yonli TS. Gourgou-Bourgade S, et al. Among authors: schmitt f. Ann Oncol. 2015 May;26(5):873-879. doi: 10.1093/annonc/mdv106. Epub 2015 Feb 27. Ann Oncol. 2015. PMID: 25725046 Free article. Review.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).
Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, A'Hern R, Bliss J, Bogaerts J, Bonnefoi H, Brain E, Cardoso MJ, Chibaudel B, Coleman R, Cufer T, Dal Lago L, Dalenc F, De Azambuja E, Debled M, Delaloge S, Filleron T, Gligorov J, Gutowski M, Jacot W, Kirkove C, MacGrogan G, Michiels S, Negreiros I, Offersen BV, Penault Llorca F, Pruneri G, Roche H, Russell NS, Schmitt F, Servent V, Thürlimann B, Untch M, van der Hage JA, van Tienhoven G, Wildiers H, Yarnold J, Bonnetain F, Mathoulin-Pélissier S, Bellera C, Dabakuyo-Yonli TS. Gourgou-Bourgade S, et al. Among authors: schmitt f. Ann Oncol. 2015 Dec;26(12):2505-6. doi: 10.1093/annonc/mdv478. Epub 2015 Oct 13. Ann Oncol. 2015. PMID: 26467471 Free article. No abstract available.
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer.
Annaratone L, Marchiò C, Renzulli T, Castellano I, Cantarella D, Isella C, Macrì L, Mariscotti G, Balmativola D, Cantanna E, Deambrogio C, Pietribiasi F, Arisio R, Schmitt F, Medico E, Sapino A. Annaratone L, et al. Among authors: schmitt f. Transl Oncol. 2012 Jun;5(3):180-9. doi: 10.1593/tlo.11343. Epub 2012 Jun 1. Transl Oncol. 2012. PMID: 22741037 Free PMC article.
Combining SKY92 gene expression profiling and FISH (according to R2-ISS) defines ultra-high-risk Multiple Myeloma.
Zhou X, Hofmann A, Engel B, Vogt C, Nerreter S, Tamamushi Y, Schmitt F, Leberzammer M, Stanojkovska E, Truger M, Xiao X, Riedhammer C, Steinhardt MJ, John M, Mersi J, Han S, Munawar U, Waldschmidt JM, Haferlach C, Einsele H, Rasche L, Kortüm KM. Zhou X, et al. Among authors: schmitt f. Hemasphere. 2025 Jan 23;9(1):e70078. doi: 10.1002/hem3.70078. eCollection 2025 Jan. Hemasphere. 2025. PMID: 39850647 Free PMC article.
Heidelberg Adult and Pediatric Airway Registry (HAPA-Registry).
Uzun DD, Bittlinger K, Wibbe E, Mohr S, Weigand MA, Schmitt FCF. Uzun DD, et al. Among authors: schmitt fcf. Methods Protoc. 2025 Jan 7;8(1):6. doi: 10.3390/mps8010006. Methods Protoc. 2025. PMID: 39846692 Free PMC article.
Pulmonary Consequences of Surgical Treatment in Children's Primary Lung Tumors: A National Retrospective Study.
Godard F, Haffreingue A, Hameury F, Sarnacki S, Hervieux E, Bonnard A, Guérin F, Rouger J, Brouard J, Vérité C, Ollivier M, Schmitt F, Scalabre A, Gambart M, Hunault MA, Sudour-Bonnange H, Buisson P, André N, Thebaud E, Habonimana E, Mansuy L, Marie-Cardine A, Lejeune J, Piolat C, Briandet C, Orbach D, Fresneau B, Reguerre Y, Mallebranche C, Rod J, Delehaye F. Godard F, et al. Among authors: schmitt f. Pediatr Blood Cancer. 2025 Mar;72(3):e31522. doi: 10.1002/pbc.31522. Epub 2025 Jan 6. Pediatr Blood Cancer. 2025. PMID: 39762635
1,346 results